<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36011562</PMID><DateCompleted><Year>2022</Year><Month>08</Month><Day>29</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>03</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1660-4601</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>16</Issue><PubDate><Year>2022</Year><Month>Aug</Month><Day>11</Day></PubDate></JournalIssue><Title>International journal of environmental research and public health</Title><ISOAbbreviation>Int J Environ Res Public Health</ISOAbbreviation></Journal><ArticleTitle>Long-Term Health Symptoms and Sequelae Following SARS-CoV-2 Infection: An Evidence Map.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">9915</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijerph19169915</ELocationID><Abstract><AbstractText>Post-COVID-19 conditions, also known as 'Long-COVID-19', describe a longer and more complex course of illness than acute COVID-19 with no widely accepted uniform case definition. We aimed to map the available evidence on persistent symptoms and sequelae following SARS-CoV-2 in children and adults. We searched the Cochrane COVID-19 Study Register and the WHO COVID-19 Global literature on coronavirus disease database on 5 November 2021. We included longitudinal and cross-sectional studies and we extracted their characteristics, including the type of core outcomes for post-COVID-19 conditions. We included 565 studies (657 records). Most studies were uncontrolled cohort studies. The median follow-up time was 13 weeks (IQR 9 to 24). Only 72% of studies were conducted in high-income countries, 93% included unvaccinated adults with mild-to-critical disease, only 10% included children and adolescents, and less than 5% included children under the age of five. While most studies focused on health symptoms, including respiratory symptoms (71%), neurological symptoms (57%), fatigue (54%), pain (50%), mental functioning (43%), cardiovascular functioning (40%), and post-exertion symptoms (28%), cognitive function (26%), fewer studies assessed other symptoms such as overall recovery (24%), the need for rehabilitation (18%), health-related quality of life (16%), changes in work/occupation and study (10%), or survival related to long-COVID-19 (4%). There is a need for controlled cohort studies with long-term follow-up and a focus on overall recovery, health-related quality of life, and the ability to perform daily tasks. Studies need to be extended to later phases of the pandemic and countries with low resources.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Franco</LastName><ForeName>Juan Victor Ariel</ForeName><Initials>JVA</Initials><Identifier Source="ORCID">0000-0003-0411-899X</Identifier><AffiliationInfo><Affiliation>Institute of General Practice, Medical Faculty, Heinrich-Heine-University D&#xfc;sseldorf, 40225 D&#xfc;sseldorf, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garegnani</LastName><ForeName>Luis Ignacio</ForeName><Initials>LI</Initials><Identifier Source="ORCID">0000-0003-4605-9473</Identifier><AffiliationInfo><Affiliation>Research Department, Instituto Universitario Hospital Italiano de Buenos Aires, Buenos Aires C1199, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oltra</LastName><ForeName>Gisela Viviana</ForeName><Initials>GV</Initials><AffiliationInfo><Affiliation>Research Department, Instituto Universitario Hospital Italiano de Buenos Aires, Buenos Aires C1199, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Metzendorf</LastName><ForeName>Maria-Inti</ForeName><Initials>MI</Initials><Identifier Source="ORCID">0000-0002-4154-5782</Identifier><AffiliationInfo><Affiliation>Institute of General Practice, Medical Faculty, Heinrich-Heine-University D&#xfc;sseldorf, 40225 D&#xfc;sseldorf, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trivisonno</LastName><ForeName>Leonel Fabrizio</ForeName><Initials>LF</Initials><Identifier Source="ORCID">0000-0002-7983-4870</Identifier><AffiliationInfo><Affiliation>Department of Health Science, Universidad Nacional de La Matanza, Buenos Aires B1754JEC, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sgarbossa</LastName><ForeName>Nadia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Health Science, Universidad Nacional de La Matanza, Buenos Aires B1754JEC, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ducks</LastName><ForeName>Denise</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Health Monitoring, Robert Koch-Institute, 13353 Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heldt</LastName><ForeName>Katharina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Health Monitoring, Robert Koch-Institute, 13353 Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mumm</LastName><ForeName>Rebekka</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Health Monitoring, Robert Koch-Institute, 13353 Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barnes</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Health Monitoring, Robert Koch-Institute, 13353 Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scheidt-Nave</LastName><ForeName>Christa</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Health Monitoring, Robert Koch-Institute, 13353 Berlin, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Environ Res Public Health</MedlineTA><NlmUniqueID>101238455</NlmUniqueID><ISSNLinking>1660-4601</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">evidence map</Keyword><Keyword MajorTopicYN="N">long-COVID-19</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>8</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>26</Day><Hour>1</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>8</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36011562</ArticleId><ArticleId IdType="pmc">PMC9408764</ArticleId><ArticleId IdType="doi">10.3390/ijerph19169915</ArticleId><ArticleId IdType="pii">ijerph19169915</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Singh A., Gupta V. SARS-CoV-2 therapeutics: How far do we stand from a remedy? Pharmacol. Rep. 2021;73:750&#x2013;768. doi: 10.1007/s43440-020-00204-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s43440-020-00204-0</ArticleId><ArticleId IdType="pmc">PMC7778692</ArticleId><ArticleId IdType="pubmed">33389724</ArticleId></ArticleIdList></Reference><Reference><Citation>Viswanathan M., Kahwati L., Jahn B., Giger K., Dobrescu A.I., Hill C., Klerings I., Meixner J., Persad E., Teufer B., et al. Universal screening for SARS-CoV-2 infection: A rapid review. Cochrane Database Syst. Rev. 2020;9:CD013718. doi: 10.1002/14651858.CD013718.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD013718</ArticleId><ArticleId IdType="pmc">PMC8453488</ArticleId><ArticleId IdType="pubmed">33502003</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiersinga W.J., Rhodes A., Cheng A.C., Peacock S.J., Prescott H.C. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. JAMA. 2020;324:782&#x2013;793. doi: 10.1001/jama.2020.12839.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12839</ArticleId><ArticleId IdType="pubmed">32648899</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M., Manoharan L., Elkheir N., Cheng V., Dagens A., Hastie C., O&#x2018;Hara M., Suett J., Dahmash D., Bugaeva P., et al. Characterising long COVID: A living systematic review. BMJ Glob. Health. 2021;6:e005427. doi: 10.1136/bmjgh-2021-005427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-005427</ArticleId><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Callard F., Perego E. How and why patients made Long COVID. Soc. Sci. Med. 2021;268:113426. doi: 10.1016/j.socscimed.2020.113426.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socscimed.2020.113426</ArticleId><ArticleId IdType="pmc">PMC7539940</ArticleId><ArticleId IdType="pubmed">33199035</ArticleId></ArticleIdList></Reference><Reference><Citation>Nabavi N. Long COVID: How to define it and how to manage it. BMJ. 2020;370:m3489. doi: 10.1136/bmj.m3489.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3489</ArticleId><ArticleId IdType="pubmed">32895219</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization (WHO) Clinical Case Definition Working Group on Post COVID-19 Condition  A Clinical Case Definition of Post COVID-19 Condition by a Delphi Consensus, 6 October 2021. 2021.  [(accessed on 22 October 2021)].  Available online:  https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC  Post-COVID Conditions.  [(accessed on 22 October 2021)];2021  Available online:  https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html.</Citation></Reference><Reference><Citation>NICE  Overview|COVID-19 Rapid Guideline: Managing the Long-Term Effects of COVID-19|Guidance|NICE.  [(accessed on 22 October 2021)].  Available online:  https://www.nice.org.uk/guidance/ng188.</Citation></Reference><Reference><Citation>Koczulla A.R., Ankermann T., Behrends U., Berlit P., B&#xf6;ing S., Brinkmann F., Franke C., Gl&#xf6;ckl R., Gogoll C., Hummel T., et al.   In: S1-Leitlinie Post-COVID/Long-COVID. Kessel S.A.M.V., Hartman T.C.O., Lucassen P.L.B.J., van Jaarsveld C.H.M., editors. AWMF; Frankfurt am Main, Germany: 2021.  [(accessed on 22 October 2021)].  Available online:  https://www.awmf.org/uploads/tx_szleitlinien/020-027l_S1_Post_COVID_Long_COVID_2021-07.pdf.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., Sepulveda R., Rebolledo P.A., Cuapio A., Villapol S. More than 50 long-term effects of COVID-19: A systematic review and meta-analysis. Sci. Rep. 2021;11:16144. doi: 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Himmels J.P.W., Qureshi S.A., Brurberg K.G., Gravningen K.M. COVID-19: Long Term Effects of COVID-19. [Langvarige effekter av COVID-19 Hurtigoversikt 2021] 2021.  [(accessed on 8 August 2022)].  Available online:  https://www.fhi.no/globalassets/dokumenterfiler/rapporter/2021/covid-19-long-term-effects-of-covid-19-report-2021.pdf.</Citation></Reference><Reference><Citation>Martimbianco A.L.C., Pacheco R.L., Bagattini M., Riera R. Frequency, signs and symptoms, and criteria adopted for long COVID-19: A systematic review. Int. J. Clin. Pract. 2021;75:e14357. doi: 10.1111/ijcp.14357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.14357</ArticleId><ArticleId IdType="pmc">PMC8236920</ArticleId><ArticleId IdType="pubmed">33977626</ArticleId></ArticleIdList></Reference><Reference><Citation>Groff D., Sun A., Ssentongo A.E., Ba D.M., Parsons N., Poudel G.R., Lekoubou A., Oh J.S., Ericson J.E., Ssentongo P., et al. Short-term and Long-term Rates of Postacute Sequelae of SARS-CoV-2 Infection: A Systematic Review. JAMA Netw. Open. 2021;4:e2128568. doi: 10.1001/jamanetworkopen.2021.28568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.28568</ArticleId><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>Kessel S.A.M.v., Hartman T.C.O., Lucassen P.L.B.J., van Jaarsveld C.H.M. Post-acute and long-COVID-19 symptoms in patients with mild diseases: A systematic review. Fam. Pract. 2021;39:159&#x2013;167. doi: 10.1093/fampra/cmab076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/fampra/cmab076</ArticleId><ArticleId IdType="pmc">PMC8414057</ArticleId><ArticleId IdType="pubmed">34268556</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwu C.J., Iwu C.D., Wiysonge C.S. The occurrence of long COVID: A rapid review. Pan Afr. Med. J. 2021;38:65. doi: 10.11604/pamj.2021.38.65.27366.</Citation><ArticleIdList><ArticleId IdType="doi">10.11604/pamj.2021.38.65.27366</ArticleId><ArticleId IdType="pmc">PMC8028365</ArticleId><ArticleId IdType="pubmed">33889231</ArticleId></ArticleIdList></Reference><Reference><Citation>Akbarialiabad H., Taghrir M.H., Abdollahi A., Ghahramani N., Kumar M., Paydar S., Razani B., Mwangi J., Asadi-Pooya A.A., Malekmakan L., et al. Long COVID, a comprehensive systematic scoping review. Infection. 2021;49:1163&#x2013;1186. doi: 10.1007/s15010-021-01666-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-021-01666-x</ArticleId><ArticleId IdType="pmc">PMC8317481</ArticleId><ArticleId IdType="pubmed">34319569</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinclair D., E Adams C. Treatment resistant schizophrenia: A comprehensive survey of randomised controlled trials. BMC Psychiatry. 2014;14:253. doi: 10.1186/s12888-014-0253-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12888-014-0253-4</ArticleId><ArticleId IdType="pmc">PMC4177431</ArticleId><ArticleId IdType="pubmed">25227719</ArticleId></ArticleIdList></Reference><Reference><Citation>Franco J.V.A., Oltra G., Metzendorf M.-I., Garegnani L.I., Ducks D., Heldt K., Mumm R., Barnes B., Scheidt-Nave C. LongCOV_521. RKI; Berlin, Germany: 2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.17605/OSF.IO/B7DWY</ArticleId></ArticleIdList></Reference><Reference><Citation>Tricco A.C., Lillie E., Zarin W., O&#x2019;Brien K.K., Colquhoun H., Levac D., Moher D., Peters M.D.J., Horsley T., Weeks L., et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Ann. Intern. Med. 2018;169:467&#x2013;473. doi: 10.7326/M18-0850.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M18-0850</ArticleId><ArticleId IdType="pubmed">30178033</ArticleId></ArticleIdList></Reference><Reference><Citation>Munblit D., Nicholson T., Akrami A., Apfelbacher C., Chen J., De Groote W., Diaz J., Gorst S.L., Harman N., Kokorina A., et al.  Core Outcome Set for Research and Clinical Practice in Post COVID-19 Condition (Long COVID): An International Delphi Consensus Study &#x2018;PC-COS&#x2019;. 2022.  [(accessed on 8 August 2022)].  Available online:  https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4017375.</Citation><ArticleIdList><ArticleId IdType="doi">10.2139/ssrn.4017375</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Long COVID Deutschland.  [(accessed on 22 October 2021)].  Available online:  https://longcoviddeutschland.org/</Citation></Reference><Reference><Citation>Metzendorf M.-I., Featherstone R.M. Evaluation of the comprehensiveness, accuracy and currency of the Cochrane COVID-19 Study Register for supporting rapid evidence synthesis production. Res. Synth. Methods. 2021;12:607&#x2013;617. doi: 10.1002/jrsm.1501.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jrsm.1501</ArticleId><ArticleId IdType="pmc">PMC8242693</ArticleId><ArticleId IdType="pubmed">34089295</ArticleId></ArticleIdList></Reference><Reference><Citation>Hausner E., Waffenschmidt S., Kaiser T., Simon M. Routine development of objectively derived search strategies. Syst. Rev. 2012;1:19. doi: 10.1186/2046-4053-1-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2046-4053-1-19</ArticleId><ArticleId IdType="pmc">PMC3351720</ArticleId><ArticleId IdType="pubmed">22587829</ArticleId></ArticleIdList></Reference><Reference><Citation>Hausner E., Guddat C., Hermanns T., Lampert U., Waffenschmidt S. Development of search strategies for systematic reviews: Validation showed the noninferiority of the objective approach. J. Clin. Epidemiol. 2015;68:191&#x2013;199. doi: 10.1016/j.jclinepi.2014.09.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2014.09.016</ArticleId><ArticleId IdType="pubmed">25464826</ArticleId></ArticleIdList></Reference><Reference><Citation>Adam G.P., Paynter R. Development of literature search strategies for evidence syntheses: Pros and cons of incorporating text mining tools and objective approaches. BMJ Evid. Based Med. 2022 doi: 10.1136/bmjebm-2021-111892.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjebm-2021-111892</ArticleId><ArticleId IdType="pubmed">35346974</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins J.P.T., Thomas J., Chandler J., Cumpston M., Li T., Page M.J., Welch V.A., editors. Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (Updated February 2021) Cochrane; London, UK: 2021.  [(accessed on 8 August 2022)].  Available online:  https://www.training.cochrane.org/handbook.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Page M.J., McKenzie J.E., Bossuyt P.M., Boutron I., Hoffmann T.C., Mulrow C.D., Shamseer L., Tetzlaff J.M., Akl E.A., Brennan S.E., et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ. 2021;88:105906. doi: 10.1136/bmj.n71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId><ArticleId IdType="pubmed">33789826</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas J., Graziosi S., Brunton J., Ghouze Z., O&#x2019;Driscoll P., Bond M., Koryakina A. EPPI-Reviewer: Advanced Software for Systematic Reviews, Maps and Evidence Synthesis. University College London; London, UK: 2022. EPPI-Centre, UCL Social Research Institute.</Citation></Reference><Reference><Citation>EPPI-Mapper. Digital Solution Foundry and EPPI-Centre; London, UK: 2022.</Citation></Reference><Reference><Citation>Chen C., Haupert S.R., Zimmermann L., Shi X., Fritsche L.G., Mukherjee B. Global Prevalence of Post COVID-19 Condition or Long COVID: A Meta-Analysis and Systematic Review. J. Infect. Dis. 2022 doi: 10.1093/infdis/jiac136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Nittas V., Gao M., West E.A., Ballouz T., Menges D., Hanson S.W., Puhan M.A. Long COVID Through a Public Health Lens: An Umbrella Review. Public Health Rev. 2022;43:1604501. doi: 10.3389/phrs.2022.1604501.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/phrs.2022.1604501</ArticleId><ArticleId IdType="pmc">PMC8963488</ArticleId><ArticleId IdType="pubmed">35359614</ArticleId></ArticleIdList></Reference><Reference><Citation>Borel M., Xie L., Kapera O., Mihalcea A., Kahn J., Messiah S.E. Long-term physical, mental and social health effects of COVID-19 in the pediatric population: A scoping review. World J. Pediatr. 2022;18:149&#x2013;159. doi: 10.1007/s12519-022-00515-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12519-022-00515-7</ArticleId><ArticleId IdType="pmc">PMC8812346</ArticleId><ArticleId IdType="pubmed">35118594</ArticleId></ArticleIdList></Reference><Reference><Citation>Ansems K., Grundeis F., Dahms K., Mikolajewska A., Thieme V., Piechotta V., Metzendorf M.-I., Stegemann M., Benstoem C., Fichtner F. Remdesivir for the treatment of COVID-19. Cochrane Database Syst. Rev. 2021;8:CD014962. doi: 10.1002/14651858.CD014962.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD014962</ArticleId><ArticleId IdType="pmc">PMC8406992</ArticleId><ArticleId IdType="pubmed">34350582</ArticleId></ArticleIdList></Reference><Reference><Citation>Popp M., Stegemann M., Riemer M., Metzendorf M.-I., Romero C.S., Mikolajewska A., Kranke P., Meybohm P., Skoetz N., Weibel S. Antibiotics for the treatment of COVID-19. Cochrane Database Syst. Rev. 2021;10:CD015025. doi: 10.1002/14651858.CD015025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD015025</ArticleId><ArticleId IdType="pmc">PMC8536098</ArticleId><ArticleId IdType="pubmed">34679203</ArticleId></ArticleIdList></Reference><Reference><Citation>Mikolajewska A., Fischer A.-L., Piechotta V., Mueller A., Metzendorf M.-I., Becker M., Dorando E., Pacheco R.L., Martimbianco A.L.C., Riera R., et al. Colchicine for the treatment of COVID-19. Cochrane Database Syst. Rev. 2021;10:CD015045. doi: 10.1002/14651858.CD015045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD015045</ArticleId><ArticleId IdType="pmc">PMC8521385</ArticleId><ArticleId IdType="pubmed">34658014</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagner C., Griesel M., Mikolajewska A., Mueller A., Nothacker M., Kley K., Metzendorf M.-I., Fischer A.-L., Kopp M., Stegemann M., et al. Systemic corticosteroids for the treatment of COVID-19. Cochrane Database Syst. Rev. 2021;8:CD014963. doi: 10.1002/14651858.CD014963.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD014963</ArticleId><ArticleId IdType="pmc">PMC8406706</ArticleId><ArticleId IdType="pubmed">34396514</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathes T., Kla&#xdf;en P., Pieper D. Frequency of data extraction errors and methods to increase data extraction quality: A methodological review. BMC Med. Res. Methodol. 2017;17:152. doi: 10.1186/s12874-017-0431-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12874-017-0431-4</ArticleId><ArticleId IdType="pmc">PMC5704562</ArticleId><ArticleId IdType="pubmed">29179685</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor K.S., Mahtani K.R., Aronson J.K. Summarising good practice guidelines for data extraction for systematic reviews and meta-analysis. BMJ Evid. Based Med. 2021;26:88&#x2013;90. doi: 10.1136/bmjebm-2020-111651.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjebm-2020-111651</ArticleId><ArticleId IdType="pubmed">33632720</ArticleId></ArticleIdList></Reference><Reference><Citation>Munblit D., Nicholson T.R., Needham D.M., Seylanova N., Parr C., Chen J., Kokorina A., Sigfrid L., Buonsenso D., Bhatnagar S., et al. Studying the post-COVID-19 condition: Research challenges, strategies, and importance of Core Outcome Set development. BMC Med. 2022;20:50. doi: 10.1186/s12916-021-02222-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-021-02222-y</ArticleId><ArticleId IdType="pmc">PMC8813480</ArticleId><ArticleId IdType="pubmed">35114994</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>